The LifeDop 300 ABI from Summit Doppler Systems is an economical, hand-held ankle brachial index (ABI) system allows clinicians to perform the exam faster. The system has a keypad feature for easily entering pressure data and calculating the indices. It stores pressure data and two ankle waveforms prior to printing.

The Vista AVS from Summit Doppler Systems Inc. is a full-featured ankle brachial index (ABI)/vascular system using different modalities for obtaining systolic pressures and waveforms. Either a bi-directional Doppler probe or pulse volume recording (PVR) can be used to obtain ankle waveforms required for reimbursement.

At ACC 2010, Philips Healthcare will focus on the full spectrum of cardiology care – from diagnosis and treatment to disease management and home monitoring to enhance patient care.

Philips Healthcare's CT systems use the iDose application that enables clinicians to reduce X-ray radiation dose by up to 80 percent.

February 8, 2010 – Partnering with leading implantable cardioverter defibrillators (ICD) and pacemaker manufacturers, ScottCare Corp. has consolidated device information into one common platform with enhanced reporting and analysis capabilities. The newst addition to the CardioView Dx suite of diagnostic solutions is OneView, designed to manage all pacer and ICD patients and information.

McKesson’s Practice Partner is an award-winning electronic health record (EHR) and medical billing software solution for physician practices which improves efficiency, quality of care, and communication while reducing time spent on administrative tasks.

February 8, 2010 – The FDA cleared the Sorin Paradym CRT Model 8750, a cardiac resynchronization therapy defibrillator (CRT-D), which features a new battery technology that delivers 37 joules, one of the highest energy levels of any implantable cardiac defibrillator (ICD).

February 5, 2010 – European CE mark approval was granted and first implants reported for the Fortify and Fortify ST implantable cardioverter defibrillators (ICD) and Unify cardiac resynchronization therapy defibrillator (CRT-D). The reduced size of these new devices compared to those of previous generations creates one of the smallest available device footprints in the industry.

February 5, 2010 – A new, large-scale pivotal phase III trial has been initiated for edoxaban to evaluate its safety and efficacy in reducing recurrent venous thromboembolic (VTE) complications in patients with deep-vein thrombosis (DVT) and/or pulmonary embolism (PE).

February 5, 2010 – Enrollment is complete for the trial of a polymer-based gel that rapidly transitions to a solid at body temperature, forming a plug that can temporarily occlude blood vessels for heart surgery.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now